VYNE Therapeutics (VYNE) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.3
-0.25
-0.19
-0.13

Details

Expected EPS
-0.173333
Actual EPS
-0.17
Surprise EPS
0
Surprise Percent
+1.92%

Description

VYNE Therapeutics (VYNE) has reported earnings of -0.17 per share for Q4 2025.

0 Comments

Share your thoughts